Abstract
Objectives
Describe outcomes among preterm infants diagnosed with single-vessel primary pulmonary vein stenosis (PPVS) initially treated using conservative management (active surveillance with deferral of treatment).
Study design
Retrospective cohort study at a single, tertiary-center (2009–2019) among infants <37 weeks’ gestation with single-vessel PPVS. Infants were classified into two categories: disease progression and disease stabilization. Cardiopulmonary outcomes were examined, and a Kaplan–Meier survival analysis performed.
Results
Twenty infants were included. Compared to infants in the stable group (0/10, 0%), all infants in the progressive group had development of at least severe stenosis or atresia (10/10, 100%; P < 0.01). Severe pulmonary hypertension at diagnosis was increased in the progressive (5/10, 50%) versus the stable group (0/10, 0%; P = 0.03). Survival was lower among infants in the progressive than the stable group (log-rank test, P < 0.01).
Conclusion
Among preterm infants with single-vessel PPVS, risk stratification may be possible, wherein more targeted, individualized therapies could be applied.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Holt DB, Moller JH, Larson S, Johnson MC. Primary pulmonary vein stenosis. Am J Cardiol. 2007;99:568–72.
Bini RM, Cleveland DC, Ceballos R, Bargeron LM Jr, Pacifico AD, Kirklin JW. Congenital pulmonary vein stenosis. Am J Cardiol. 1984;54:369–75.
Kalfa D, Belli E, Bacha E, Lambert V, di Carlo D, Kostolny M, et al. Primary pulmonary vein stenosis: outcomes, risk factors, and severity score in a multicentric study. Ann Thorac Surg. 2017;104:182–9.
Latson LA, Prieto LR. Congenital and acquired pulmonary vein stenosis. Circulation. 2007;115:103–8.
del Cerro MJ, Sabate Rotes A, Carton A, Deiros L, Bret M, Cordeiro M, et al. Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes. Pediatr Pulmonol. 2014;49:49–59.
Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric pulmonary hypertension: guidelines from the american heart association and american thoracic society. Circulation. 2015;132:2037–99.
Krishnan U, Feinstein JA, Adatia I, Austin ED, Mullen MP, Hopper RK, et al. Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia. J Pediatr. 2017;188:24–34.e1.
Kanaan UB, Mahle WT. New paradigms for pulmonary vein stenosis treatment: when surgery and transcatheter therapy aren’t good enough. J Pediatr. 2018;198:12–3.
Rosenblum JM, Altin HF, Gillespie SE, Bauser-Heaton H, Kanter KA, Sinha R, et al. Management outcomes of primary pulmonary vein stenosis. J Thorac Cardiovasc Surg. 2020;159:1029–36.e1.
Drossner DM, Kim D, Maher KO, Mahle WT. Prematurity is a strong risk factor for developing pulmonary vein stenosis. J Am Coll Cardiol. 2008;51:A378–9.
Drossner DM, Kim DW, Maher KO, Mahle WT. Pulmonary vein stenosis: prematurity and associated conditions. Pediatrics. 2008;122:E656–61.
Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach. Am J Respir Crit Care Med. 2019;200:751–9.
Carlton EF, Sontag MK, Younoszai A, DiMaria MV, Miller JI, Poindexter BB, et al. Reliability of echocardiographic indicators of pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. J Pediatr. 2017;186:29–33.
Callahan R, Kieran MW, Baird CW, Colan SD, Gauvreau K, Ireland CM, et al. Adjunct targeted biologic inhibition agents to treat aggressive multivessel intraluminal pediatric pulmonary vein stenosis. J Pediatr. 2018;198:29–35.e5.
Mahgoub L, Kaddoura T, Kameny AR, Lopez Ortego P, Vanderlaan RD, Kakadekar A, et al. Pulmonary vein stenosis of ex-premature infants with pulmonary hypertension and bronchopulmonary dysplasia, epidemiology, and survival from a multicenter cohort. Pediatr Pulmonol. 2017;52:1063–70.
Hong H. Commentary: management outcomes of primary pulmonary vein stenosis: what we know now and what we can expect in the future. J Thorac Cardiovasc Surg. 2020;159:1039.
Cory MJ, Ooi YK, Kelleman MS, Vincent RN, Kim DW, Petit CJ. Reintervention is associated with improved survival in pediatric patients with pulmonary vein stenosis. JACC Cardiovasc Interv. 2017;10:1788–98.
Bergersen L, Gauvreau K, Foerster SR, Marshall AC, McElhinney DB, Beekman RH 3rd, et al. Catheterization for congenital heart disease adjustment for risk method (CHARM). JACC Cardiovasc Interv. 2011;4:1037–46.
Bergersen L, Gauvreau K, Marshall A, Kreutzer J, Beekman R, Hirsch R, et al. Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv. 2011;4:188–94.
Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002;123:110–8.
Backes CH, Nealon E, Armstrong AK, Cua CL, Mitchell C, Krishnan U, et al. Pulmonary vein stenosis in infants: a systematic review, meta-analysis, and meta-regression. J Pediatr. 2018;198:36–45.e3.
Lo Rito M, Gazzaz T, Wilder TJ, Vanderlaan RD, Van Arsdell GS, Honjo O, et al. Pulmonary vein stenosis: severity and location predict survival after surgical repair. J Thorac Cardiovasc Surg. 2016;151:657–66.e2.
Levy PT, Jain A, Nawaytou H, Teitel D, Keller R, Fineman J, et al. Risk assessment and monitoring of chronic pulmonary hypertension in premature infants. J Pediatr. 2020;217:199–209.e4.
Vanderlaan RD, Honjo O. Commentary: it takes a village: changing the trajectory of pulmonary vein stenosis outcomes. J Thorac Cardiovasc Surg. 2020;159:1037–8.
Morales-Nebreda L, Chung CS, Agrawal R, Yeldandi AV, Singer BD, Bharat A, et al. Headed in the wrong direction: chronic and acute derangements in pulmonary blood flow distribution in a patient with severe pulmonary vein stenosis. Ann Am Thorac Soc. 2019;16:1321–6.
Heching HJ, Turner M, Farkouh-Christiana, Krishnan U. Pulmonary vein stenosis and necrotising enterocolitis: is there a possible link with necrotising enterocolitis? Arch Dis Child Fetal Neonatal Ed. 2014;99:F282–5.
Swier NL, Richards B, Cua CL, Lynch SK, Yin H, Nelin LD, et al. Pulmonary vein stenosis in neonates with severe bronchopulmonary dysplasia. Am J Perinatol. 2016;33:671–7.
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.
Funding
The authors (CB, JS, and BC) are funded by the National Heart, Lung, and Blood Institute of the US National Institutes of Health (R01HL145032, R01HL13693). However, this funding is unrelated to the topic of this article and did not contribute to this work product.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zettler, E., Rivera, B.K., Stiver, C. et al. Primary pulmonary vein stenosis among premature infants with single-vessel disease. J Perinatol 41, 1621–1626 (2021). https://doi.org/10.1038/s41372-020-00830-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-020-00830-9